LFA
Legacy Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $665K | Sell |
1,641
-614
| -27% | -$249K | 0.1% | 171 |
|
2025
Q1 | $1.12M | Buy |
2,255
+127
| +6% | +$63.2K | 0.19% | 94 |
|
2024
Q4 | $1.11M | Sell |
2,128
-41
| -2% | -$21.3K | 0.18% | 93 |
|
2024
Q3 | $1.34M | Buy |
2,169
+54
| +3% | +$33.4K | 0.23% | 74 |
|
2024
Q2 | $1.17M | Buy |
2,115
+144
| +7% | +$79.6K | 0.21% | 76 |
|
2024
Q1 | $1.15M | Buy |
1,971
+120
| +6% | +$69.7K | 0.21% | 86 |
|
2023
Q4 | $983K | Buy |
1,851
+433
| +31% | +$230K | 0.19% | 86 |
|
2023
Q3 | $718K | Buy |
1,418
+265
| +23% | +$134K | 0.14% | 96 |
|
2023
Q2 | $602K | Sell |
1,153
-149
| -11% | -$77.7K | 0.11% | 113 |
|
2023
Q1 | $750K | Buy |
1,302
+201
| +18% | +$116K | 0.15% | 78 |
|
2022
Q4 | $606K | Buy |
1,101
+103
| +10% | +$56.7K | 0.13% | 92 |
|
2022
Q3 | $506K | Buy |
998
+79
| +9% | +$40.1K | 0.12% | 95 |
|
2022
Q2 | $499K | Sell |
919
-11
| -1% | -$5.97K | 0.12% | 90 |
|
2022
Q1 | $549K | Buy |
930
+14
| +2% | +$8.27K | 0.12% | 94 |
|
2021
Q4 | $611K | Buy |
916
+20
| +2% | +$13.3K | 0.14% | 72 |
|
2021
Q3 | $512K | Buy |
896
+172
| +24% | +$98.3K | 0.13% | 74 |
|
2021
Q2 | $365K | Buy |
724
+37
| +5% | +$18.7K | 0.09% | 100 |
|
2021
Q1 | $314K | Buy |
687
+56
| +9% | +$25.6K | 0.09% | 104 |
|
2020
Q4 | $294K | Buy |
631
+40
| +7% | +$18.6K | 0.08% | 99 |
|
2020
Q3 | $261K | Buy |
+591
| New | +$261K | 0.08% | 97 |
|
2019
Q2 | – | Sell |
-591
| Closed | -$162K | – | 828 |
|
2019
Q1 | $162K | Buy |
591
+141
| +31% | +$38.7K | 0.05% | 120 |
|
2018
Q4 | $101K | Buy |
450
+196
| +77% | +$44K | 0.04% | 143 |
|
2018
Q3 | $61K | Buy |
254
+17
| +7% | +$4.08K | 0.02% | 225 |
|
2018
Q2 | $50K | Buy |
237
+28
| +13% | +$5.91K | 0.02% | 252 |
|
2018
Q1 | $44K | Hold |
209
| – | – | 0.02% | 258 |
|
2017
Q4 | $39K | Buy |
+209
| New | +$39K | 0.02% | 279 |
|